According to the results, majority of SLC25s expression were negatively correlated with stromal (Figure 6(a)), immune (Figure 6(b)), and estimate (Figure 6(c)) scores in most cancer types, while SLC25A8 expression was positively correlated with the majority cancers. This evidence concerns the gene UCP2 and cancer.